Base de dados : MEDLINE
Pesquisa : C11.300.500 [Categoria DeCS]
Referências encontradas : 478 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 48 ir para página                         

  1 / 478 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29391860
[Au] Autor:Galor A; Small L; Feuer W; Levitt RC; Sarantopoulos KD; Yosipovitch G
[Ad] Endereço:Miami Veterans Administration Medical Center, Miami, Florida (Dr Galor); Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miami, Florida (Dr Galor, Dr Small, Mr Feuer); and Department of Anesthesiology, Perioperative Medicine and Pain Management (Dr Levitt, Dr Sarantopo
[Ti] Título:The Relationship Between Ocular Itch, Ocular Pain, and Dry Eye Symptoms (An American Ophthalmological Society Thesis).
[So] Source:Trans Am Ophthalmol Soc;115:T5, 2017 Aug.
[Is] ISSN:1545-6110
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Purpose: To evaluate associations between sensations of ocular itch and dry eye (DE) symptoms, including ocular pain, and DE signs. Methods: A cross-sectional study of 324 patients seen in the Miami Veterans Affairs eye clinic was performed. The evaluation consisted of questionnaires regarding ocular itch, DE symptoms, descriptors of neuropathic-like ocular pain (NOP), and evoked pain sensitivity testing on the forehead and forearm, followed by a comprehensive ocular surface examination including corneal mechanical sensitivity testing. Analyses were performed to examine for differences between those with and without subjective complaints of ocular itch. Results: The mean age was 62 years with 92% being male. Symptoms of DE and NOP were more frequent in patients with moderate-severe ocular itch compared to those with no or mild ocular itch symptoms. With the exception of ocular surface inflammation (abnormal matrix metalloproteinase 9 testing) which was less common in those with moderate-severe ocular itch symptoms, DE signs were not related to ocular itch. Individuals with moderate-severe ocular itch also demonstrated greater sensitivity to evoked pain on the forearm and had higher non-ocular pain, depression, and post-traumatic stress disorders scores, compared to those with no or mild itch symptoms. Conclusions: Subjects with moderate-severe ocular itch symptoms have more severe symptoms of DE, NOP, non-ocular pain and demonstrate abnormal somatosensory testing in the form of increased sensitivity to evoked pain at a site remote from the eye, consistent with generalized hypersensitivity.
[Mh] Termos MeSH primário: Síndromes do Olho Seco/diagnóstico
Oftalmopatias/diagnóstico
Dor Ocular/diagnóstico
Prurido/diagnóstico
[Mh] Termos MeSH secundário: Córnea/fisiologia
Estudos Transversais
Síndromes do Olho Seco/fisiopatologia
Oftalmopatias/fisiopatologia
Dor Ocular/fisiopatologia
Feminino
Seres Humanos
Masculino
Meia-Idade
Oftalmologia/organização & administração
Medição da Dor
Prurido/fisiopatologia
Qualidade de Vida
Fenômenos Fisiológicos da Pele
Sociedades Médicas
Inquéritos e Questionários
Lágrimas/fisiologia
Estados Unidos
Veteranos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180216
[Lr] Data última revisão:
180216
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE


  2 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29212484
[Au] Autor:Chen L; Jiang L; Yang B; Subramanian PS
[Ad] Endereço:Department of Ophthalmology, Hainan Branch of Chinese People's Liberation Army General Hospital, Sanya, Hainan, China.
[Ti] Título:Clinical features of visual disturbances secondary to isolated sphenoid sinus inflammatory diseases.
[So] Source:BMC Ophthalmol;17(1):237, 2017 Dec 06.
[Is] ISSN:1471-2415
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Visual disturbances associated with isolated sphenoid sinus inflammatory diseases (ISSIDs) are easily misdiagnosed due to the nonspecific symptoms and undetectable anatomical location. The main objective of this retrospective case series is to investigate the clinical features of visual disturbances secondary to ISSIDs. METHODS: Clinical data of 23 patients with unilateral or bilateral visual disturbances secondary to ISSIDs from 2004 to 2014 with new symptoms were collected. Collected data including symptoms, signs, neuroimaging and pathologic diagnosis were analyzed. RESULTS: There were 14 males and 9 females, and their ages ranged from 31 to 83 years. Fifteen patients suffered blurred vision and 11 patients suffered binocular double vision, including 3 patients who had unilateral visual changes and diplopia simultaneously. Headache was observed in 18 patients, and orbit pain/ocular pain in 8 patients. Other presenting symptoms included ptosis (4 patients) and proptosis (1 patient). Only 5 patients had nasal complaints. The corrected visual acuities were between NLP to 20/20. Patients with diplopia included 5 with unilateral oculomotor nerve palsy and 6 with unilateral abducens nerve palsy. All patients performed orbital/sinus/brain radiologic examination and found responsible lesions in sphenoid sinus. All patients underwent endoscopic sinus surgery, and 9 patients were found to suffer sphenoid mucocele, 9 with fungal sinusitis, and 5 with sphenoid sinusitis. Visual disturbances improved in 6 patients, and all the patients with diplopia had a postoperative recovery. CONCLUSION: Visual disturbances resulting from ISSIDs are relatively uncommon, but it is crucial that the patient with new vision loss or diplopia and persistent headache or orbit pain be evaluated for the possibility of ISSIDs especially before corticosteroid administration.
[Mh] Termos MeSH primário: Doenças dos Seios Paranasais/complicações
Seio Esfenoidal
Transtornos da Visão/etiologia
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Dor Ocular/etiologia
Feminino
Cefaleia/etiologia
Seres Humanos
Masculino
Meia-Idade
Doenças do Nervo Oculomotor/etiologia
Doenças dos Seios Paranasais/patologia
Estudos Retrospectivos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171226
[Lr] Data última revisão:
171226
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171208
[St] Status:MEDLINE
[do] DOI:10.1186/s12886-017-0634-9


  3 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29068979
[Au] Autor:Den Beste KA; Okeke C
[Ad] Endereço:aDepartment of Ophthalmology, Eastern Virginia Medical School bVirginia Eye Consultants, Norfolk, VA.
[Ti] Título:Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: A case report.
[So] Source:Medicine (Baltimore);96(43):e7936, 2017 Oct.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: Bilateral acute iris transillumination (BAIT) is a poorly-understood ocular syndrome in which patients present with acute iridocyclitis and pigmentary dispersion with or without ocular hypertension. The etiology of the disease remains unknown, though recent reports suggest an antecedent upper respiratory tract infection or systemic antibiotic administration may trigger the clinical syndrome. PATIENT CONCERNS: A 55-year-old female was referred for a second opinion regarding her bilateral ocular pain, photophobia, and ocular hypertension. Her medical history was notable for a diagnosis of pneumonia managed with oral moxifloxacin several weeks prior to her initial presentation. DIAGNOSES: Visual acuity was 20/40 with an intraocular pressure (IOP) of 30 mmHg in the affected eye despite maximal tolerated medical therapy. The patient had severe bilateral iris transillumination defects with posterior synechiae formation and 3+ pigment with rare cell in the anterior chamber. This constellation of findings was consistent with a diagnosis of BAIT. INTERVENTIONS: A peripheral iridotomy was placed, which mildly relieved the iris bowing, but did not affect the IOP or inflammatory reaction. The patient then underwent cataract extraction with posterior synechiolysis and ab interno trabeculotomy of the left eye with the Trabectome. OUTCOMES: The patient's IOP on the first post-operative day was 13 mmHg, and anterior chamber inflammation was noted to be significantly reduced at post-operative week 2. The patient was recently seen at a 1-year post-operative visit and her IOP remains in the low teens on a low-dose combination topical agent. LESSONS: Ophthalmologists should remain aware of the association between systemic fluoroquinolones and acute pigmentary dispersion that can progress to glaucoma. The Trabectome remains a viable option for management of pigmentary and uveitic glaucoma resistant to medical treatment.
[Mh] Termos MeSH primário: Antibacterianos/efeitos adversos
Fluoroquinolonas/efeitos adversos
Glaucoma de Ângulo Aberto/induzido quimicamente
Glaucoma de Ângulo Aberto/cirurgia
Trabeculectomia/métodos
[Mh] Termos MeSH secundário: Extração de Catarata
Dor Ocular/induzido quimicamente
Feminino
Seres Humanos
Meia-Idade
Hipertensão Ocular/induzido quimicamente
Fotofobia/induzido quimicamente
Pneumonia Bacteriana/tratamento farmacológico
Trabeculectomia/instrumentação
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Fluoroquinolones); U188XYD42P (moxifloxacin)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171123
[Lr] Data última revisão:
171123
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171026
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000007936


  4 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29055360
[Au] Autor:Dieckmann G; Goyal S; Hamrah P
[Ad] Endereço:Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
[Ti] Título:Neuropathic Corneal Pain: Approaches for Management.
[So] Source:Ophthalmology;124(11S):S34-S47, 2017 Nov.
[Is] ISSN:1549-4713
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Neuropathic pain is caused by a primary lesion or dysfunction of the nervous system and can occur in the cornea. However, neuropathic corneal pain (NCP) is currently an ill-defined disease. Patients with NCP are extremely challenging to manage, and evidence-based clinical recommendations for the management of patients with NCP are scarce. The objectives of this review are to provide guidelines for diagnosis and treatment of patients with NCP and to summarize current evidence-based literature in this area. We performed a systematic literature search of all relevant publications between 1966 and 2017. Treatment recommendations are, in part, based on methodologically sound randomized controlled trials (RCTs), demonstrating superiority to placebo or relevant control treatments, and on the consistency of evidence, degree of efficacy, and safety. In addition, the recommendations include our own extensive experience in the management of these patients over the past decade. A comprehensive algorithm, based on clinical evaluation and complementary tests, is presented for diagnosis and subcategorization of patients with NCP. Recommended first-line topical treatments include neuroregenerative and anti-inflammatory agents, and first-line systemic pharmacotherapy includes tricyclic antidepressants and an anticonvulsant. Second-line oral treatments recommended include an opioid-antagonist and opiate analgesics. Complementary and alternative treatments, such as cardiovascular exercise, acupuncture, omega-3 fatty acid supplementation, and gluten-free diet, may have additional benefits, as do potential noninvasive and invasive procedures in recalcitrant cases. Medication selection should be tailored on an individual basis, considering side effects, comorbidities, and levels of peripheral and centralized pain. Nevertheless, there is an urgent need for long-term studies and RCTs assessing the efficacy of treatments for NCP.
[Mh] Termos MeSH primário: Doenças da Córnea/terapia
Dor Ocular/terapia
Neuralgia/terapia
[Mh] Termos MeSH secundário: Córnea/inervação
Doenças da Córnea/diagnóstico
Dor Ocular/diagnóstico
Seres Humanos
Neuralgia/diagnóstico
Nervo Trigêmeo/fisiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171027
[Lr] Data última revisão:
171027
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171023
[St] Status:MEDLINE


  5 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28528121
[Au] Autor:Satitpitakul V; Kheirkhah A; Crnej A; Hamrah P; Dana R
[Ad] Endereço:Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
[Ti] Título:Determinants of Ocular Pain Severity in Patients With Dry Eye Disease.
[So] Source:Am J Ophthalmol;179:198-204, 2017 Jul.
[Is] ISSN:1879-1891
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: To quantify the severity of ocular pain in patients with dry eye disease (DED) and evaluate factors associated with pain severity. DESIGN: Cross-sectional study. METHODS: Eighty-four patients with DED were asked to score their severity level of ocular pain using a 10-point scale, with 10 indicating the most severe pain. All patients also had a comprehensive ophthalmic assessment including a detailed history, Ocular Surface Disease Index (OSDI) questionnaire, and ocular surface examination. Regression analysis was used to determine the factors associated with ocular pain severity. RESULTS: The mean OSDI score was 45.6 ± 23.1. At least some degree of ocular pain (score >1) was reported by 88.1% of patients, including mild pain (scores 2-4) in 46.4%, moderate pain (scores 5-7) in 34.5%, and severe pain (scores 8-10) in 7.1% of patients. Ocular pain levels significantly correlated with the OSDI score (r = 0.49, P < .001). Regression analysis showed that the severity of ocular pain had a significant association with use of antidepressant medications (P = .045) but not with tear breakup time, corneal fluorescein staining, or ocular medications used by patients. In patients without pain, a significant correlation was seen between OSDI and corneal fluorescein staining scores (r = 0.67, P = .01). However, such a correlation was not observed in those with ocular pain. CONCLUSIONS: A majority of patients with DED report some degree of ocular pain, which correlates only moderately with the OSDI score. Severity of ocular pain correlates with nonocular comorbidities such as use of antidepressant medications rather than with clinical signs of DED.
[Mh] Termos MeSH primário: Síndromes do Olho Seco/complicações
Dor Ocular/diagnóstico
Medição da Dor/métodos
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Estudos Transversais
Síndromes do Olho Seco/diagnóstico
Dor Ocular/epidemiologia
Dor Ocular/etiologia
Feminino
Seres Humanos
Incidência
Masculino
Massachusetts/epidemiologia
Meia-Idade
Índice de Gravidade de Doença
Inquéritos e Questionários
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170721
[Lr] Data última revisão:
170721
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170522
[St] Status:MEDLINE


  6 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28367946
[Au] Autor:Ota T; Yamazaki M; Toda Y; Ozawa A; Kimura K
[Ad] Endereço:Department of Neurological Science, Chiba Hokusoh Hospital, Nippon Medical School.
[Ti] Título:A case of herpes zoster ophthalmicus preceded one week by diplopia and ophthalmalgia.
[So] Source:Rinsho Shinkeigaku;57(4):163-167, 2017 04 28.
[Is] ISSN:1882-0654
[Cp] País de publicação:Japan
[La] Idioma:jpn
[Ab] Resumo:A 66-year-old man presented with headache and ophthalmalgia. Diplopia developed, and he was hospitalized. The left eye had abducent paralysis and proptosis. We diagnosed him with Tolosa-Hunt syndrome and administered methylprednisolone at 1 g/day for 3 days. However, the patient did not respond to treatment. No abnormality was found on his MRI or cerebrospinal fluid examination. Tests showed his serum immunoglobulin G4 and antineutrophil cytoplasmic antibody titers were within normal limits. He also had untreated diabetes mellitus (HbA1c 9.2). One week after first presenting with symptoms, herpes zoster appeared on the patient's dorsum nasi, followed by keratitis and a corneal ulcer. Herpes zoster ophthalmicus with ophthalmoplegia was diagnosed. We began treatment with acyclovir (15 mg/kg) and prednisolone (1 mg/kg, decreased gradually). Ophthalmalgia and the eruption improved immediately. The eye movement disorder improved gradually over several months. It is rare that diplopia appears prior to cingulate eruption of herpes zoster ophthalmicus. We speculated that onset of the eruption was inhibited by strong steroid therapy and untreated diabetes mellitus.
[Mh] Termos MeSH primário: Diplopia/etiologia
Dor Ocular/etiologia
Herpes Zoster Oftálmico/complicações
[Mh] Termos MeSH secundário: Aciclovir/administração & dosagem
Idoso
Complicações do Diabetes/complicações
Diplopia/tratamento farmacológico
Quimioterapia Combinada
Dor Ocular/tratamento farmacológico
Herpes Zoster Oftálmico/diagnóstico
Herpes Zoster Oftálmico/tratamento farmacológico
Seres Humanos
Masculino
Oftalmoplegia/complicações
Oftalmoplegia/diagnóstico
Oftalmoplegia/tratamento farmacológico
Prednisolona/administração & dosagem
Fatores de Tempo
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
9PHQ9Y1OLM (Prednisolone); X4HES1O11F (Acyclovir)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:171012
[Lr] Data última revisão:
171012
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170404
[St] Status:MEDLINE
[do] DOI:10.5692/clinicalneurol.cn-000972


  7 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28299439
[Au] Autor:Ozen S; Ozer MA; Akdemir MO
[Ad] Endereço:Section of Surgical Sciences, Department of Ophthalmology, Faculty of Medicine, Giresun University, Debboy, 28100, Giresun, Turkey. serkan_zen@hotmail.com.
[Ti] Título:Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
[So] Source:Graefes Arch Clin Exp Ophthalmol;255(6):1173-1177, 2017 Jun.
[Is] ISSN:1435-702X
[Cp] País de publicação:Germany
[La] Idioma:eng
[Ab] Resumo:PURPOSE: This study aims to understand the effect of vitamin B12 deficiency on neuropathic ocular pain (NOP) and symptoms in patients with dry eye disease (DED). METHODS: Patients with severe DED (without receiving topical artificial tears treatment) and ocular pain were enrolled (n = 90). Patients with severe DED and vitamin B12 deficiency (group 1, n = 45) received parenteral vitamin B12 supplement + topical treatment (artificial tears treatment + cyclosporine), and patients with severe DED and normal serum vitamin B12 level (group 2, n = 45) received only topical treatment (artificial tears treatment + cyclosporine). Patients were evaluated by the ocular surface disease index (OSDI) questionnaire, 3rd question (have you experienced painful or sore eyes during last week?) score of OSDI as a pain determiner and pain frequency measure), tear break up time (TBUT), and Schirmer's type 1 test. We compared the groups' OSDI, TBUT, and Schirmer's test recordings at the first visit and after 12 weeks retrospectively. RESULTS: The OSDI score, 3rd OSDI question score, TBUT, and Schirmer's test results improved after 12 weeks (p < 0.001 for each group). The mean vitamin B12 level at enrollment was 144.24 ±43.36 pg/ml in group 1 and 417.53 ±87.22 pg/ml in group 2. The mean vitamin B12 level in group 1 reached to 450 ±60.563 pg/ml after 12 weeks of treatment. The mean score changes between the groups were not statistically significant; however, the decrease in the OSDI questionnaire score (-30.80 ±5.24) and 3rd OSDI question score (-2.82 ±0.53) were remarkable in group 1 (Table 2). The mean TBUT increase was +7.98 ±2.90 s and Schirmer's test result increase was +12.16 ±2.01 mm in group 1. The mean TBUT increase was +6.18 ±1.49 s and Schirmer's test result increase was +6.71 ±1.47 mm in group 2. CONCLUSIONS: These findings indicate that vitamin B12 deficiency is related with NOP. It may be important to consider measuring the serum vitamin B12 level in patients with severe DED presenting with resistant ocular pain despite taking topical treatment.
[Mh] Termos MeSH primário: Síndromes do Olho Seco/tratamento farmacológico
Dor Ocular/tratamento farmacológico
Lubrificantes Oftálmicos/administração & dosagem
Deficiência de Vitamina B 12/complicações
Vitamina B 12/administração & dosagem
[Mh] Termos MeSH secundário: Administração Tópica
Adulto
Dor Crônica
Síndromes do Olho Seco/complicações
Síndromes do Olho Seco/metabolismo
Dor Ocular/etiologia
Feminino
Seguimentos
Seres Humanos
Masculino
Estudos Retrospectivos
Resultado do Tratamento
Vitamina B 12/farmacocinética
Deficiência de Vitamina B 12/tratamento farmacológico
Deficiência de Vitamina B 12/metabolismo
Complexo Vitamínico B/administração & dosagem
Complexo Vitamínico B/farmacocinética
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Lubricant Eye Drops); 12001-76-2 (Vitamin B Complex); P6YC3EG204 (Vitamin B 12)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:171005
[Lr] Data última revisão:
171005
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170317
[St] Status:MEDLINE
[do] DOI:10.1007/s00417-017-3632-y


  8 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28276953
[Au] Autor:Ji J; Dimitrijevic I; Sundquist J; Sundquist K; Zöller B
[Ad] Endereço:a Centre for Primary Health Care Research , Lund University/Region Skåne , Malmö , Sweden.
[Ti] Título:Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden.
[So] Source:Scand J Rheumatol;46(6):484-489, 2017 Nov.
[Is] ISSN:1502-7732
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: No large-scale nationwide study has determined the risk of ocular manifestations in patients with giant cell arteritis (GCA). The aim was to study the incidence and risk factors of ocular manifestations in patients with GCA in Sweden. METHOD: A national cohort was created by linking Swedish nationwide registers. GCA patients were identified from the Swedish Hospital Inpatient and Outpatient Registers between 2002 and 2010, and were followed until the development of ocular manifestations. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were calculated for ocular manifestations in patients with GCA compared to those without GCA. RESULTS: We identified 3737 males and 8311 females with GCA. A total of 1618 individuals had subsequent ocular manifestations, representing 13.4% of the GCA patients. The overall SIR of ocular manifestations was 6.96 (95% CI 6.63-7.31). The risk for disorders of the optic nerve or visual tract was particularly high (SIR = 51.68, 95% CI 46.12-57.73). Men with GCA had a higher risk than women, and GCA patients without polymyalgia rheumatica (PMR) symptoms had a higher risk than those with PMR symptoms. Living outside big cities was negatively associated with ocular manifestations in GCA patients, whereas hypertension and diabetes were associated with an increased risk of ocular manifestations. CONCLUSION: The overall risk of ocular manifestations was higher in GCA patients than in the general population, especially for men and for those without PMR symptoms.
[Mh] Termos MeSH primário: Oftalmopatias/epidemiologia
Arterite de Células Gigantes/epidemiologia
Polimialgia Reumática/epidemiologia
[Mh] Termos MeSH secundário: Idoso
Amaurose Fugaz/epidemiologia
Cegueira/epidemiologia
Cidades
Estudos de Coortes
Diabetes Mellitus/epidemiologia
Diplopia/epidemiologia
Dor Ocular/epidemiologia
Feminino
Seres Humanos
Hipertensão/epidemiologia
Incidência
Masculino
Distribuição Espacial da População
Oclusão da Artéria Retiniana/epidemiologia
Oclusão da Veia Retiniana/epidemiologia
Fatores de Risco
Fatores Sexuais
Suécia
Baixa Visão/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171107
[Lr] Data última revisão:
171107
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170310
[St] Status:MEDLINE
[do] DOI:10.1080/03009742.2016.1266030


  9 / 478 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28234682
[Au] Autor:Peracha-Riyaz MH; Peracha ZH; Spaulding J; Baciu P; Ahmed S; Imami NR; Darnley-Fisch D; Desai U
[Ad] Endereço:Henry Ford Health System Department of Ophthalmology, Detroit, MI.
[Ti] Título:First Described Case of Anterior and Posterior Segment Crystals in Phacolytic Glaucoma.
[So] Source:J Glaucoma;26(5):e171-e173, 2017 May.
[Is] ISSN:1536-481X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Phacolytic glaucoma is an open-angle glaucoma that occurs when lens proteins from hypermature cataracts seep through an intact anterior capsule and induce obstruction of the trabecular meshwork by inflammatory cells. We review the case of a 66-year-old man who presented with acute pain, a hypermature cataract, prominent anterior chamber crystals, and elevated intraocular pressure. After cataract surgery was performed, iridescent crystals were noted in the posterior chamber. Anterior chamber crystals have been associated with phacolytic glaucoma, but this is the first case demonstrating crystals in the posterior chamber as well.
[Mh] Termos MeSH primário: Segmento Anterior do Olho/patologia
Catarata/complicações
Cristalinas/efeitos adversos
Glaucoma de Ângulo Aberto/etiologia
Segmento Posterior do Olho/patologia
[Mh] Termos MeSH secundário: Idoso
Cristalização
Dor Ocular/etiologia
Glaucoma de Ângulo Aberto/diagnóstico
Glaucoma de Ângulo Aberto/cirurgia
Seres Humanos
Pressão Intraocular
Iridectomia
Masculino
Facoemulsificação
Tonometria Ocular
Malha Trabecular/patologia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Crystallins)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171027
[Lr] Data última revisão:
171027
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170225
[St] Status:MEDLINE
[do] DOI:10.1097/IJG.0000000000000642


  10 / 478 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28233891
[Au] Autor:Querques L; Miserocchi E; Modorati G; Querques G; Bandello F
[Ad] Endereço:Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita-Salute, Milan - Italy.
[Ti] Título:Hemorrhagic occlusive retinal vasculitis after inadvertent intraocular perforation with gentamycin injection.
[So] Source:Eur J Ophthalmol;27(2):e50-e53, 2017 Mar 10.
[Is] ISSN:1724-6016
[Cp] País de publicação:Italy
[La] Idioma:eng
[Ab] Resumo:PURPOSE: To report a case of hemorrhagic occlusive retinal vasculitis (HORV) secondary to intraocular toxicity due to inadvertent intraocular injection of gentamycin. METHODS: A 21-year-old woman was referred to our department because of severe ocular pain and sudden visual loss in her left eye after she received a subconjunctival gentamycin injection for chronic infectious keratitis. RESULTS: At presentation, best-corrected visual acuity was 20/20 in the right eye and counting fingers in the left eye. Fundus examination showed diffuse intraretinal and perivascular hemorrhages, vascular cuffing, white-centered hemorrhages, and diffuse retinal edema. Fluorescein angiography confirmed occlusive retinal vasculitis with capillary nonperfusion and spectral-domain optical coherence tomography revealed ischemic macular edema. The clinical diagnosis was compatible with HORV secondary to retinal toxicity due to high dose of intraocular gentamycin. CONCLUSIONS: We report a case of HORV secondary to inadvertent subconjunctival gentamycin injection. Ocular perforation and high dose of intravitreal gentamycin administration should be considered as a potential cause of HORV following subconjunctival injection.
[Mh] Termos MeSH primário: Antibacterianos/efeitos adversos
Gentamicinas/efeitos adversos
Ferimentos Penetrantes Produzidos por Agulha/etiologia
Hemorragia Retiniana/induzido quimicamente
Perfurações Retinianas/etiologia
Vasculite Retiniana/induzido quimicamente
[Mh] Termos MeSH secundário: Cegueira/etiologia
Úlcera da Córnea/tratamento farmacológico
Úlcera da Córnea/microbiologia
Infecções Oculares Bacterianas/tratamento farmacológico
Infecções Oculares Bacterianas/microbiologia
Dor Ocular/etiologia
Feminino
Angiofluoresceinografia
Seres Humanos
Doença Iatrogênica
Injeções Intraoculares
Ferimentos Penetrantes Produzidos por Agulha/diagnóstico
Hemorragia Retiniana/diagnóstico
Perfurações Retinianas/diagnóstico
Vasculite Retiniana/diagnóstico
Tomografia de Coerência Óptica
Acuidade Visual/efeitos dos fármacos
Adulto Jovem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Gentamicins)
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170330
[Lr] Data última revisão:
170330
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170225
[St] Status:MEDLINE



página 1 de 48 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde